Indices of platelet activation and the stability of coronary artery disease

Aim:  To determine whether indices of platelet activation are associated with the stability of coronary artery disease (CAD). Methods:  Platelet function was examined in 677 consecutive aspirin‐treated patients presenting for cardiac catheterization. Patients were grouped into recent myocardial infa...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of thrombosis and haemostasis 2007-04, Vol.5 (4), p.761-765
Hauptverfasser: LINDEN, M. D., FURMAN, M. I., FRELINGER, A.L., FOX, M. L., BARNARD, M. R., LI, Y., PRZYKLENK, K., MICHELSON, A. D.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 765
container_issue 4
container_start_page 761
container_title Journal of thrombosis and haemostasis
container_volume 5
creator LINDEN, M. D.
FURMAN, M. I.
FRELINGER, A.L.
FOX, M. L.
BARNARD, M. R.
LI, Y.
PRZYKLENK, K.
MICHELSON, A. D.
description Aim:  To determine whether indices of platelet activation are associated with the stability of coronary artery disease (CAD). Methods:  Platelet function was examined in 677 consecutive aspirin‐treated patients presenting for cardiac catheterization. Patients were grouped into recent myocardial infarction (MI), no MI but angiographically documented CAD (non‐MI CAD) and no angiographically detectible CAD (no CAD), as well as additional subgroups. Results:  Compared with non‐MI CAD or no CAD patients, more patients with recent MI had a shortened platelet function analyzer (PFA)‐100 collagen‐epinephrine closure time (CT) and increased circulating monocyte‐platelet aggregates, neutrophil‐platelet aggregates, activated platelet surface GPIIb‐IIIa and plasma soluble CD40 ligand (sCD40L). More patients with non‐MI CAD had shortened PFA‐100 CTs and increased monocyte‐platelet aggregates compared with patients with no CAD. Platelet surface P‐selectin did not differ among the groups. Subgroup analysis revealed that decreasing PFA‐100 CT correlated with the stability of CAD. Conclusions:  Indices of platelet activation, especially the PFA‐100 CT, are associated with the stability of CAD, and may reflect plaque instability, an ongoing thrombotic state and/or reduced responsiveness to aspirin.
doi_str_mv 10.1111/j.1538-7836.2007.02462.x
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_70343214</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>70343214</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4172-a9387d40db85a030394b56665ab88c5009e434525c707001555bfe00ad0d43a73</originalsourceid><addsrcrecordid>eNqNkD1PwzAQQC0EolD4C8gTW8I5tmNnYEAV0EIlljJbju0IV2lSYhfaf09CC6zccifduw89hDCBlPRxs0wJpzIRkuZpBiBSyFiepdsjdPbbOP6pC0pH6DyEJQApeAanaEQEFYTJ4gw9zxrrjQu4rfC61tHVLmJtov_Q0bcN1o3F8c3hEHXpax93A2jarm10t8O6i65P1geng7tAJ5Wug7s85DF6fbhfTKbJ_OVxNrmbJ4YRkSW6oFJYBraUXAMFWrCS53nOdSml4QCFY5TxjBsBov-Zc15WDkBbsIxqQcfoer933bXvGxeiWvlgXF3rxrWboARQRjPCelDuQdO1IXSuUuvOr_rHFQE1iFRLNThSgy81iFTfItW2H7063NiUK2f_Bg_meuB2D3z62u3-vVg9LaZDRb8Ar8-AjA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>70343214</pqid></control><display><type>article</type><title>Indices of platelet activation and the stability of coronary artery disease</title><source>MEDLINE</source><source>EZB-FREE-00999 freely available EZB journals</source><source>Alma/SFX Local Collection</source><creator>LINDEN, M. D. ; FURMAN, M. I. ; FRELINGER, A.L. ; FOX, M. L. ; BARNARD, M. R. ; LI, Y. ; PRZYKLENK, K. ; MICHELSON, A. D.</creator><creatorcontrib>LINDEN, M. D. ; FURMAN, M. I. ; FRELINGER, A.L. ; FOX, M. L. ; BARNARD, M. R. ; LI, Y. ; PRZYKLENK, K. ; MICHELSON, A. D.</creatorcontrib><description>Aim:  To determine whether indices of platelet activation are associated with the stability of coronary artery disease (CAD). Methods:  Platelet function was examined in 677 consecutive aspirin‐treated patients presenting for cardiac catheterization. Patients were grouped into recent myocardial infarction (MI), no MI but angiographically documented CAD (non‐MI CAD) and no angiographically detectible CAD (no CAD), as well as additional subgroups. Results:  Compared with non‐MI CAD or no CAD patients, more patients with recent MI had a shortened platelet function analyzer (PFA)‐100 collagen‐epinephrine closure time (CT) and increased circulating monocyte‐platelet aggregates, neutrophil‐platelet aggregates, activated platelet surface GPIIb‐IIIa and plasma soluble CD40 ligand (sCD40L). More patients with non‐MI CAD had shortened PFA‐100 CTs and increased monocyte‐platelet aggregates compared with patients with no CAD. Platelet surface P‐selectin did not differ among the groups. Subgroup analysis revealed that decreasing PFA‐100 CT correlated with the stability of CAD. Conclusions:  Indices of platelet activation, especially the PFA‐100 CT, are associated with the stability of CAD, and may reflect plaque instability, an ongoing thrombotic state and/or reduced responsiveness to aspirin.</description><identifier>ISSN: 1538-7933</identifier><identifier>ISSN: 1538-7836</identifier><identifier>EISSN: 1538-7836</identifier><identifier>DOI: 10.1111/j.1538-7836.2007.02462.x</identifier><identifier>PMID: 17371489</identifier><language>eng</language><publisher>Oxford, UK: Blackwell Publishing Ltd</publisher><subject>Aged ; Anti-Inflammatory Agents, Non-Steroidal - pharmacology ; aspirin ; Aspirin - pharmacology ; CD40 Ligand - metabolism ; coronary artery disease ; Coronary Artery Disease - blood ; Coronary Artery Disease - diagnosis ; Coronary Artery Disease - therapy ; Epinephrine - metabolism ; Female ; flow cytometry ; Humans ; Male ; Middle Aged ; Neutrophils - metabolism ; P-Selectin - biosynthesis ; PFA‐100 ; Platelet Activation ; Platelet Function Tests ; Platelet Glycoprotein GPIIb-IIIa Complex - metabolism ; platelets</subject><ispartof>Journal of thrombosis and haemostasis, 2007-04, Vol.5 (4), p.761-765</ispartof><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4172-a9387d40db85a030394b56665ab88c5009e434525c707001555bfe00ad0d43a73</citedby><cites>FETCH-LOGICAL-c4172-a9387d40db85a030394b56665ab88c5009e434525c707001555bfe00ad0d43a73</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/17371489$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>LINDEN, M. D.</creatorcontrib><creatorcontrib>FURMAN, M. I.</creatorcontrib><creatorcontrib>FRELINGER, A.L.</creatorcontrib><creatorcontrib>FOX, M. L.</creatorcontrib><creatorcontrib>BARNARD, M. R.</creatorcontrib><creatorcontrib>LI, Y.</creatorcontrib><creatorcontrib>PRZYKLENK, K.</creatorcontrib><creatorcontrib>MICHELSON, A. D.</creatorcontrib><title>Indices of platelet activation and the stability of coronary artery disease</title><title>Journal of thrombosis and haemostasis</title><addtitle>J Thromb Haemost</addtitle><description>Aim:  To determine whether indices of platelet activation are associated with the stability of coronary artery disease (CAD). Methods:  Platelet function was examined in 677 consecutive aspirin‐treated patients presenting for cardiac catheterization. Patients were grouped into recent myocardial infarction (MI), no MI but angiographically documented CAD (non‐MI CAD) and no angiographically detectible CAD (no CAD), as well as additional subgroups. Results:  Compared with non‐MI CAD or no CAD patients, more patients with recent MI had a shortened platelet function analyzer (PFA)‐100 collagen‐epinephrine closure time (CT) and increased circulating monocyte‐platelet aggregates, neutrophil‐platelet aggregates, activated platelet surface GPIIb‐IIIa and plasma soluble CD40 ligand (sCD40L). More patients with non‐MI CAD had shortened PFA‐100 CTs and increased monocyte‐platelet aggregates compared with patients with no CAD. Platelet surface P‐selectin did not differ among the groups. Subgroup analysis revealed that decreasing PFA‐100 CT correlated with the stability of CAD. Conclusions:  Indices of platelet activation, especially the PFA‐100 CT, are associated with the stability of CAD, and may reflect plaque instability, an ongoing thrombotic state and/or reduced responsiveness to aspirin.</description><subject>Aged</subject><subject>Anti-Inflammatory Agents, Non-Steroidal - pharmacology</subject><subject>aspirin</subject><subject>Aspirin - pharmacology</subject><subject>CD40 Ligand - metabolism</subject><subject>coronary artery disease</subject><subject>Coronary Artery Disease - blood</subject><subject>Coronary Artery Disease - diagnosis</subject><subject>Coronary Artery Disease - therapy</subject><subject>Epinephrine - metabolism</subject><subject>Female</subject><subject>flow cytometry</subject><subject>Humans</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Neutrophils - metabolism</subject><subject>P-Selectin - biosynthesis</subject><subject>PFA‐100</subject><subject>Platelet Activation</subject><subject>Platelet Function Tests</subject><subject>Platelet Glycoprotein GPIIb-IIIa Complex - metabolism</subject><subject>platelets</subject><issn>1538-7933</issn><issn>1538-7836</issn><issn>1538-7836</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2007</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNkD1PwzAQQC0EolD4C8gTW8I5tmNnYEAV0EIlljJbju0IV2lSYhfaf09CC6zccifduw89hDCBlPRxs0wJpzIRkuZpBiBSyFiepdsjdPbbOP6pC0pH6DyEJQApeAanaEQEFYTJ4gw9zxrrjQu4rfC61tHVLmJtov_Q0bcN1o3F8c3hEHXpax93A2jarm10t8O6i65P1geng7tAJ5Wug7s85DF6fbhfTKbJ_OVxNrmbJ4YRkSW6oFJYBraUXAMFWrCS53nOdSml4QCFY5TxjBsBov-Zc15WDkBbsIxqQcfoer933bXvGxeiWvlgXF3rxrWboARQRjPCelDuQdO1IXSuUuvOr_rHFQE1iFRLNThSgy81iFTfItW2H7063NiUK2f_Bg_meuB2D3z62u3-vVg9LaZDRb8Ar8-AjA</recordid><startdate>200704</startdate><enddate>200704</enddate><creator>LINDEN, M. D.</creator><creator>FURMAN, M. I.</creator><creator>FRELINGER, A.L.</creator><creator>FOX, M. L.</creator><creator>BARNARD, M. R.</creator><creator>LI, Y.</creator><creator>PRZYKLENK, K.</creator><creator>MICHELSON, A. D.</creator><general>Blackwell Publishing Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>200704</creationdate><title>Indices of platelet activation and the stability of coronary artery disease</title><author>LINDEN, M. D. ; FURMAN, M. I. ; FRELINGER, A.L. ; FOX, M. L. ; BARNARD, M. R. ; LI, Y. ; PRZYKLENK, K. ; MICHELSON, A. D.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4172-a9387d40db85a030394b56665ab88c5009e434525c707001555bfe00ad0d43a73</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2007</creationdate><topic>Aged</topic><topic>Anti-Inflammatory Agents, Non-Steroidal - pharmacology</topic><topic>aspirin</topic><topic>Aspirin - pharmacology</topic><topic>CD40 Ligand - metabolism</topic><topic>coronary artery disease</topic><topic>Coronary Artery Disease - blood</topic><topic>Coronary Artery Disease - diagnosis</topic><topic>Coronary Artery Disease - therapy</topic><topic>Epinephrine - metabolism</topic><topic>Female</topic><topic>flow cytometry</topic><topic>Humans</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Neutrophils - metabolism</topic><topic>P-Selectin - biosynthesis</topic><topic>PFA‐100</topic><topic>Platelet Activation</topic><topic>Platelet Function Tests</topic><topic>Platelet Glycoprotein GPIIb-IIIa Complex - metabolism</topic><topic>platelets</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>LINDEN, M. D.</creatorcontrib><creatorcontrib>FURMAN, M. I.</creatorcontrib><creatorcontrib>FRELINGER, A.L.</creatorcontrib><creatorcontrib>FOX, M. L.</creatorcontrib><creatorcontrib>BARNARD, M. R.</creatorcontrib><creatorcontrib>LI, Y.</creatorcontrib><creatorcontrib>PRZYKLENK, K.</creatorcontrib><creatorcontrib>MICHELSON, A. D.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of thrombosis and haemostasis</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>LINDEN, M. D.</au><au>FURMAN, M. I.</au><au>FRELINGER, A.L.</au><au>FOX, M. L.</au><au>BARNARD, M. R.</au><au>LI, Y.</au><au>PRZYKLENK, K.</au><au>MICHELSON, A. D.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Indices of platelet activation and the stability of coronary artery disease</atitle><jtitle>Journal of thrombosis and haemostasis</jtitle><addtitle>J Thromb Haemost</addtitle><date>2007-04</date><risdate>2007</risdate><volume>5</volume><issue>4</issue><spage>761</spage><epage>765</epage><pages>761-765</pages><issn>1538-7933</issn><issn>1538-7836</issn><eissn>1538-7836</eissn><abstract>Aim:  To determine whether indices of platelet activation are associated with the stability of coronary artery disease (CAD). Methods:  Platelet function was examined in 677 consecutive aspirin‐treated patients presenting for cardiac catheterization. Patients were grouped into recent myocardial infarction (MI), no MI but angiographically documented CAD (non‐MI CAD) and no angiographically detectible CAD (no CAD), as well as additional subgroups. Results:  Compared with non‐MI CAD or no CAD patients, more patients with recent MI had a shortened platelet function analyzer (PFA)‐100 collagen‐epinephrine closure time (CT) and increased circulating monocyte‐platelet aggregates, neutrophil‐platelet aggregates, activated platelet surface GPIIb‐IIIa and plasma soluble CD40 ligand (sCD40L). More patients with non‐MI CAD had shortened PFA‐100 CTs and increased monocyte‐platelet aggregates compared with patients with no CAD. Platelet surface P‐selectin did not differ among the groups. Subgroup analysis revealed that decreasing PFA‐100 CT correlated with the stability of CAD. Conclusions:  Indices of platelet activation, especially the PFA‐100 CT, are associated with the stability of CAD, and may reflect plaque instability, an ongoing thrombotic state and/or reduced responsiveness to aspirin.</abstract><cop>Oxford, UK</cop><pub>Blackwell Publishing Ltd</pub><pmid>17371489</pmid><doi>10.1111/j.1538-7836.2007.02462.x</doi><tpages>5</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1538-7933
ispartof Journal of thrombosis and haemostasis, 2007-04, Vol.5 (4), p.761-765
issn 1538-7933
1538-7836
1538-7836
language eng
recordid cdi_proquest_miscellaneous_70343214
source MEDLINE; EZB-FREE-00999 freely available EZB journals; Alma/SFX Local Collection
subjects Aged
Anti-Inflammatory Agents, Non-Steroidal - pharmacology
aspirin
Aspirin - pharmacology
CD40 Ligand - metabolism
coronary artery disease
Coronary Artery Disease - blood
Coronary Artery Disease - diagnosis
Coronary Artery Disease - therapy
Epinephrine - metabolism
Female
flow cytometry
Humans
Male
Middle Aged
Neutrophils - metabolism
P-Selectin - biosynthesis
PFA‐100
Platelet Activation
Platelet Function Tests
Platelet Glycoprotein GPIIb-IIIa Complex - metabolism
platelets
title Indices of platelet activation and the stability of coronary artery disease
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-08T17%3A35%3A57IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Indices%20of%20platelet%20activation%20and%20the%20stability%20of%20coronary%20artery%20disease&rft.jtitle=Journal%20of%20thrombosis%20and%20haemostasis&rft.au=LINDEN,%20M.%20D.&rft.date=2007-04&rft.volume=5&rft.issue=4&rft.spage=761&rft.epage=765&rft.pages=761-765&rft.issn=1538-7933&rft.eissn=1538-7836&rft_id=info:doi/10.1111/j.1538-7836.2007.02462.x&rft_dat=%3Cproquest_cross%3E70343214%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=70343214&rft_id=info:pmid/17371489&rfr_iscdi=true